The short version
- Why people research itFocus, memory, neuroprotection, mood and stress resilience.
- What the evidence isReached phase 2 in humans — trialed by Aevi Genomic Medicine for ADHD in adolescents with specific mGluR gene mutations.
- What to watchIrritability, agitation or mood swings.
How Fasoracetam works
Upregulates GABA-B and metabotropic glutamate receptors — calmer, anxiolytic-leaning cognition.
Fasoracetam is (+)-5-oxo-D-prolinepiperidinamide monohydrate, developed as NS-105 Hirouchi 2000. Structurally that is a pyroglutamate — a cyclized glutamate — amidated onto a piperidine ring, which makes it a cousin of the racetams by shape and a relative of glutamate by origin.
What was actually shown, and it is unusually precise for this shelf. Two papers dissected its effect on adenylyl cyclase in rat brain using selective antagonists and antisense knockdown Oka 1997 Hirouchi 2000. In rat cerebrocortical membranes, fasoracetam at 0.1 micromolar inhibited forskolin-stimulated cAMP formation, and that inhibition was blocked by a group II mGlu antagonist and by a group III antagonist (MAP-4) but not by the group I antagonist AIDA.
- Oral
On the goal map: Glutamatergic & synaptic plasticity (Focus, memory & cognition)
Research on Fasoracetam5 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Human clinical evidence
Reached phase 2 in humans — trialed by Aevi Genomic Medicine for ADHD in adolescents with specific mGluR gene mutations. The trial missed its primary endpoint, and the company discontinued it.
Worth noting what was being asked: a genetically stratified ADHD population on a specific rating scale. A miss there is not a general verdict, though it is the only controlled test the compound has had.
Correlative data
Community use for anxiety and ADHD-adjacent complaints. Reported experience includes a distinctive lack of tolerance, and some users report it restores sensitivity to other racetams.
How the mechanism reads
Upregulates metabotropic glutamate receptors and acts on GABA-B — a mechanism unlike any other racetam. The mGluR upregulation is why the ADHD trial selected on mGluR mutations.
MechanisticReceptor upregulation rather than direct agonism predicts both the slow onset and the reported absence of tolerance — you are increasing receptor density, not fatiguing it.
Mechanistic
Sources
- Elia J, Ungal G, Kao C, Ambrosini A, De Jesus-Rosario N, Larsen L, Chiavacci R, Wang T, Kurian C, Titchen K, Sykes B, Hwang S, Kumar B, Potts J, Davis J, Malatack J, Slattery E, Moorthy G, Zuppa A, Weller A, Byrne E, Li YR, Kraft WK, Hakonarson H. Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling.. Nat Commun 2018 · PMID 29339723
- Hirouchi M. Role of metabotropic glutamate receptor subclasses in modulation of adenylyl cyclase activity by a nootropic NS-105.. Eur J Pharmacol 2000 · PMID 10633154
- Oka M. Involvement of metabotropic glutamate receptors in Gi- and Gs-dependent modulation of adenylate cyclase activity induced by a novel cognition enhancer NS-105 in rat brain.. Brain Res 1997 · PMID 9134967
- Ogasawara T. Involvement of cholinergic and GABAergic systems in the reversal of memory disruption by NS-105, a cognition enhancer.. Pharmacol Biochem Behav 1999 · PMID 10494996
- Aevi Genomic Medicine Inc. Top-Line Results from Placebo-Controlled ASCEND Trial (Parts A & B) of AEVI-001 in Children with ADHD.. Company announcement, 2 January 2019
Fasoracetam safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Severe kidney impairment, since racetams are cleared unchanged by the kidney.
- Bipolar disorder, since glutamate-system modulation can tip mood upward.
- Taking baclofen, phenibut or GHB, which act on the same GABA-B system.
- Pregnancy or breastfeeding, as racetams cross the placenta and milk.
What’s expected
- A calmer, less reactive focus from GABA-B and metabotropic glutamate upregulation.
- Headache or restlessness early on.
- Better tolerability than efficacy data in the adolescent ADHD trial.
Watch for
- Irritability, agitation or mood swings.
- Sleep that shortens in the first days of a glutamate-active drug.
- Marked sedation if combined with another GABA-B drug.
Labs that tell you it’s working
- Cystatin C with eGFR: renal clearance of the unchanged drug sets how long it stays.
- Comprehensive Metabolic Panel: baseline liver and electrolytes.
Racetam that upregulates GABA-B and metabotropic glutamate receptors; the safety dataset is a 178-participant adolescent ADHD trial. PMID 29339723 PMID 10633154
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Fasoracetam FAQ4 common questions
- Is Fasoracetam approved for human use?
- No. Fasoracetam is a research compound.
- What is Fasoracetam researched for?
- Focus, memory, neuroprotection, mood and stress resilience.
- Which labs show whether it's doing anything?
- Cystatin C with eGFR; Comprehensive Metabolic Panel: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Fasoracetam: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



